The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Friedmann Nadav since 2005.
This trader's CIK number is 1245267.
At the time of last reporting, Friedmann Nadav was the Chief Medical Officer of Cassava Sciences Inc. (stock ticker symbol SAVA).
Also see all insider trading activities at Cassava Sciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | SAVA | 0 | $0 | 0 | $0 | 46,766 | $672,781 |
| 2021 | SAVA | 0 | $0 | 0 | $0 | 28,015 | $1,500,203 |
| 2014 | SAVA | 0 | $0 | 0 | $0 | 257,388 | $1,168,541 |
| 2011 | SAVA | 0 | $0 | 75,000 | $353,421 | 1,346,958 | $6,896,424 |
| 2010 | SAVA | 0 | $0 | 30,000 | $181,800 | 0 | $0 |
| 2009 | SAVA | 18,374 | $90,554 | 15,000 | $75,000 | 0 | $0 |
| 2008 | SAVA | 28,267 | $20,575 | 0 | $0 | 0 | $0 |
| 2007 | SAVA | 4,709 | $21,259 | 12,000 | $103,520 | 0 | $0 |
| 2006 | SAVA | 5,475 | $24,254 | 41,000 | $406,830 | 0 | $0 |
| 2005 | SAVA | 54,121 | $118,247 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-10-03 | SAVA | Option Ex | 9,376 | .95 | 8,907 |
| 2022-10-03 | SAVA | Option Ex | 9,376 | .95 | 8,907 |
| 2022-05-27 | SAVA | Option Ex | 28,014 | 23.38 | 654,967 |
| 2021-03-17 | SAVA | Option Ex | 28,015 | 53.55 | 1,500,203 |
| 2014-07-01 | PTIE | Option Ex | 135,334 | 4.54 | 614,416 |
| 2014-04-09 | PTIE | Option Ex | 122,054 | 4.54 | 554,125 |
| 2011-10-18 | PTIE | Sale | 25,000 | 4.44 | 111,000 |
| 2011-10-03 | PTIE | Sale | 8,000 | 4.89 | 39,120 |
| 2011-09-30 | PTIE | Sale | 10,000 | 4.91 | 49,060 |
| 2011-10-04 | PTIE | Sale | 7,000 | 4.59 | 32,116 |
| 2011-09-15 | PTIE | Sale | 25,000 | 4.88 | 122,125 |
| 2011-07-05 | PTIE | Option Ex | 625,084 | 5.12 | 3,200,430 |
| 2011-06-22 | PTIE | Option Ex | 200,000 | 5.12 | 1,024,000 |
| 2011-06-13 | PTIE | Option Ex | 425,084 | 5.12 | 2,176,430 |
| 2011-06-01 | PTIE | Option Ex | 96,790 | 5.12 | 495,564 |
| 2010-05-04 | PTIE | Sale | 15,000 | 5.95 | 89,205 |
| 2010-04-01 | PTIE | Sale | 15,000 | 6.17 | 92,595 |
| 2009-12-07 | PTIE | Buy | 15,000 | 5.19 | 77,835 |
| 2009-11-16 | PTIE | Sale | 15,000 | 5.00 | 75,000 |
| 2009-05-01 | PTIE | Buy | 3,374 | 3.77 | 12,719 |
| 2008-08-01 | PTIE | Buy | 25,000 | .00 | 0 |
| 2008-05-01 | PTIE | Buy | 3,267 | 6.30 | 20,575 |
| 2007-11-01 | PTIE | Buy | 193 | 6.50 | 1,254 |
| 2007-05-01 | PTIE | Buy | 4,516 | 4.43 | 20,005 |
| 2007-02-28 | PTIE | Sale | 4,000 | 7.85 | 31,400 |
| 2007-01-31 | PTIE | Sale | 4,000 | 8.90 | 35,600 |
| 2006-12-29 | PTIE | Sale | 4,000 | 9.13 | 36,520 |
| 2006-11-30 | PTIE | Sale | 4,000 | 8.59 | 34,360 |
| 2006-11-01 | PTIE | Buy | 1,321 | 4.43 | 5,852 |
| 2006-10-31 | PTIE | Sale | 4,000 | 8.32 | 33,280 |
| 2006-09-29 | PTIE | Sale | 4,000 | 8.54 | 34,160 |
| 2006-08-31 | PTIE | Sale | 4,000 | 8.37 | 33,480 |
| 2006-05-01 | PTIE | Buy | 4,154 | 4.43 | 18,402 |
| 2006-03-15 | PTIE | Sale | 25,000 | 10.86 | 271,550 |
| 2005-11-01 | PTIE | Buy | 4,121 | 4.43 | 18,247 |
| 2005-10-28 | PTIE | Buy | 25,000 | 2.00 | 50,000 |
| 2005-10-10 | PTIE | Buy | 15,000 | 2.00 | 30,000 |
| 2005-10-05 | PTIE | Buy | 10,000 | 2.00 | 20,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Friedmann Nadav (Chief Medical Officer of Cassava Sciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.